Anti-Cancer Medicine Manufacturer in India: Driving Innovation and Accessibility
Introduction Cancer is one of the leading causes of death worldwide, and India is no exception. Anti-cancer medicines, also known as oncology drugs , are designed to slow, stop, or reverse the growth of cancer cells. They play a pivotal role in extending life expectancy, improving quality of life, and in many cases, achieving remission. In India, the cancer burden is significant. According to the Indian Council of Medical Research (ICMR) , over 1.4 million new cancer cases are reported annually, with breast, cervical, lung, and colorectal cancers being the most common. The rising prevalence highlights the urgent need for effective and affordable anti-cancer treatments, creating opportunities for local pharmaceutical manufacturers like Medyra Pharmaceutica . Market Overview of Anti-Cancer Medicines in India The Indian oncology drug market has been expanding rapidly, driven by increased awareness, improved diagnostic facilities, and government initiatives. As per recent ma...